Encision Azione

Encision Conversione FCF

Delisted·10 lug 2026

Il Tasso di Conversione FCF (FCF/EBITDA) di Encision (ECIA) al 18 ago 2026 è 59,47 %. L'anno precedente, Tasso di Conversione FCF (FCF/EBITDA) era 61,30 % — una variazione del -2,98% (inferiore).

Conversione FCF

59,47 %

YoY

-2,98%

Ultimo aggiornamento:

Tasso di Conversione FCF (FCF/EBITDA) di Encision ammonta a 2026 59,47 % . Tasso di Conversione FCF (FCF/EBITDA) di Encision ammontava a 2025 61,30 % . Diminuisce del -2,98% inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Encision Analisi delle Azioni

Cosa fa Encision? Encision Inc is a leading provider of precision instruments for minimally invasive surgery, based in Boulder, Colorado. The company's history can be traced back to 1991 when it was founded by Kenneth Messier, an experienced surgeon. At that time, minimally invasive surgery was becoming increasingly popular as it offered patients smaller scars and less pain. However, the technology was not yet perfected and problems, particularly with the use of high-frequency electrocautery, kept arising. Messier recognized this problem and developed an innovative solution: AEM technology (Active Electrode Monitoring). Together with a colleague, Mark Weinstein, he founded Encision Inc to bring this technology to the market. Since then, the company has evolved into a leading provider of precision tools for minimally invasive surgery. Encision's business model is based on the production and distribution of medical devices and related consumables. Encision offers a wide range of surgical instruments, including AEM and non-AEM electrocautery devices, surgical monitors, fine cutting instruments, and trocars. These devices are used in various surgical disciplines such as gynecology, urology, and general medicine. One of Encision's main areas of focus is AEM technology, which reduces the risk of unintentional tissue burns during electrocautery. The AEM system continuously monitors the electrical impedance of the tissue and adjusts the high-frequency power as needed. Another important area for Encision is the development of disposable products such as electrodes, needles, and tubing sets. These products are intended for single-use and help minimize infection risks. Encision has also specialized in the development of instruments for laparoscopic surgery, a minimally invasive technique in which the operation is performed through small incisions in the body. Encision's laparoscopy instruments offer precise control and high performance to meet the demands of surgeons. Encision has sold over 2,500 devices to clinics and healthcare providers in North America and Europe. Most of the products are registered and certified in the USA. Encision places great emphasis on quality and innovation. The company has strict quality control measures to maintain the highest standards in production and the development of new products. Furthermore, it is committed to constantly developing new technologies and expanding its portfolio to meet customer needs. Overall, Encision Inc has experienced strong growth in recent years and has become a leading provider of surgical instruments in the minimally invasive surgery industry. With its focus on quality, innovation, and customer satisfaction, the company has built a solid reputation in the industry and is expected to continue being a key player in the future. The answer is "Encision Inc is a leading provider of precision instruments for minimally invasive surgery, based in Boulder, Colorado." Encision è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Encision azioni

Tasso di Conversione FCF (FCF/EBITDA) di Encision è 59,47 % nel 2026.

Il Tasso di Conversione FCF (FCF/EBITDA) di Encision è passato da 61,30 % a 59,47 %, con una variazione del -2,98 %. Il valore è inferiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Encision di Tasso di Conversione FCF (FCF/EBITDA) dal 2006, con valori annuali, grafici e analisi dettagliate.

La conversione FCF misura l'efficacia con cui l'EBITDA si converte in flusso di cassa libero. Una conversione più elevata indica un'efficiente allocazione di capitale e bassi costi di manutenzione.

Un 'buono' varia a seconda del settore e della fase di sviluppo dell'azienda. Su Eulerpool puoi confrontare Encision di Tasso di Conversione FCF (FCF/EBITDA) con i competitor del settore e la media industriale per valutare se è attraente.

Per valutare di Tasso di Conversione FCF (FCF/EBITDA), è essenziale confrontarlo con i competitor nello stesso settore e industria. Su Eulerpool puoi trovare confronti diretti con l'industria per Tasso di Conversione FCF (FCF/EBITDA).

Access this data via the Eulerpool API

Flussi di cassa — Encision

Tutte le Metriche Finanziarie — Encision